Not Yet RecruitingNot Applicable

Validity and Reliability of the Turkish Form of the Enjoyment of Physical Activity Scale-8 in Geriatrics With Minimal Cognitive Impairment

Turkey (Türkiye)100 participantsStarted 2026-05-15

Plain-language summary

The main objective of this study is to examine the validity and reliability of the Turkish form of the Enjoyment of Physical Activity Scale-8 (PACES-8) in individuals aged 65 and over with Minimal Cognitive Impairment (MCI).

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being 65 years of age or older, * Having a diagnosis of Minimal Cognitive Impairment (MCI), * Having a Standardized Mini Mental Test (SMMT) score between 24 and 27 (mild cognitive impairment level), * Being largely independent in daily living activities (absence of functional dependency), * Being able to mobilize independently, * Having the communication level to understand and answer the survey questions, * Volunteering to participate in the study and providing written informed consent. Exclusion Criteria: * Diagnosis of dementia or advanced cognitive impairment, * Acute medical conditions that prevent participation in physical activity, * Severe vision or hearing loss, * Presence of neurological or psychiatric disorders that prevent completion of questionnaire forms, * Serious neurological event within the last 6 months (stroke, traumatic brain injury, etc.).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Physical Activity Enjoyment Scale-8 (PACES-8):

Timeframe: 1 week

Trial details

NCT IDNCT07588685

SponsorIstanbul University - Cerrahpasa

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06-15

Contact for this trial

GULFİDAN TOKGÖZ, Lecturer, PhD (c)

0552 022 76 32 gulfidan.tokgoz@gmail.com

View on ClinicalTrials.gov More Geriatric trials

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.